Journal article icon

Journal article

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients

Abstract:

Objective: To assess the safety and efficacy of the Genous™ endothelial progenitor cell (EPC) capturing stent in conjunction with HmG-CoA-reductase inhibitors (statins) to stimulate EPC recruitment, in the treatment of patients with de novo coronary artery lesions. Methods and results: The HEALING IIB study was a multi-center, prospective trial, including 100 patients. The primary efficacy endpoint was late luminal loss by QCA at 6-month follow-up (FU). Although statin therapy increased relat...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
Atherosclerosis
Volume:
219
Issue:
1
Pages:
245-252
Publication date:
2011-11-05
DOI:
EISSN:
1879-1484
ISSN:
0021-9150
URN:
uuid:955c65c3-8614-402b-8de8-1a0d2fea7d95
Source identifiers:
206196
Local pid:
pubs:206196

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP